BioCentury
ARTICLE | Company News

ADx NeuroSciences, Catholic University Leuven deal

November 14, 2011 8:00 AM UTC

ADx NeuroSciences received exclusive, worldwide rights from the university to develop and commercialize undisclosed antibodies that selectively bind phosphorylated Tau aggregates for use in diagnostic...